Daiichi Sankyo is a prominent global pharmaceutical company rooted in Japan, boasting over 125 years of scientific expertise. With a commitment to innovation and patient care, the company operates in more than 30 countries and regions worldwide, driven by a workforce of over 19,000 dedicated employees. Daiichi Sankyo specializes in developing innovative pharmaceuticals, including both new and generic medicines, aiming to address a diverse array of medical needs.

The company's robust research and development pipeline, along with its state-of-the-art drug discovery and delivery methods, illustrate its dedication to enriching the quality of life for patients globally. In fiscal year 2024, Daiichi Sankyo reported substantial revenues and significant investment in R&D, reflecting its ongoing commitment to advancing healthcare. Core values such as innovation, integrity, and accountability guide the company, as it strives to be a leader in the global healthcare sector and contribute to the sustainable development of society